Published in AIDS Weekly, June 9th, 2003
Moreover, Mayo's experiments in mice suggest that the presence or absence of this mutation in the gene known as Vpr may play a central role in determining which HIV-infected patients develop full-blown, fatal AIDS.
If these findings hold up, this "good guy" mutation could lead to new AIDS therapies based upon Vpr inhibitors to reduce immune-system cell death during HIV infection. By preserving these immune system cells - known...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2003-06-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.